How big is the South Korea Oral Anti-Diabetic Drug Market?

The South Korea Oral Anti-Diabetic Drug Market size is expected to reach USD 0.95 billion in 2024 and grow at a CAGR of 3.80% to reach USD 1.14 billion by 2029. Read More

What is the current South Korea Oral Anti-Diabetic Drug Market size?

In 2024, the South Korea Oral Anti-Diabetic Drug Market size is expected to reach USD 0.95 billion. Read More

Who are the key players in South Korea Oral Anti-Diabetic Drug Market?

Eli Lilly and Company, Astellas, Sanofi, Janseen and Astrazeneca are the major companies operating in the South Korea Oral Anti-Diabetic Drug Market. Read More

What years does this South Korea Oral Anti-Diabetic Drug Market cover, and what was the market size in 2023?

In 2023, the South Korea Oral Anti-Diabetic Drug Market size was estimated at USD 0.91 billion. The report covers the South Korea Oral Anti-Diabetic Drug Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the South Korea Oral Anti-Diabetic Drug Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

South Korea Oral Anti-Diabetic Drug Companies

This report lists the top South Korea Oral Anti-Diabetic Drug companies based on the 2023 & 2024 market share reports. Mordor Intelligence expert advisors conducted extensive research and identified these brands to be the leaders in the South Korea Oral Anti-Diabetic Drug industry.